Lapidus Cytyc Corp. is developing a machine that can identify abnormal cells in pap smear cultures.
Stan Lapidus's first company, Itran Corp., uses imaging technology for industrial quality control. His new company will use imaging to check Pap smears. Seems all 50 million cervical-cancer tests done in the United States each year are inspected individually by people viewing scores of slides a day. Lapidus's Cytyc Corp., in Marlborough, Mass., is developing a machine that can identify cultures with abnormal cells. Expected benefits: a 30% to 50% decline in Pap-smear costs and a 500% increase in lab workers' productivity.